ID | 1538 | |
PMID | 22386653 | |
Year | 2012 | |
Sequence | QNPASPPEEGSPDPDSTGA LVEEEDPFFKVPVNKLA AAVSNFGYDLYRVRSSTS PTTNVLLSPLSVATAL SALSLGAEQRTESIIHR ALYYDLISSPDIHGTYKEL LDTVTAPQKNLKSAS RIVFEKKLRIKSSFVAPLE KSYGTRPRVLTGNP RLDLQEINNWVQAQ MKGKLARSTKEIPDEIS ILLLGVAHFKGQWVTKF DSRKTSLEDFYLDEER TVRVPMMSDPKAVLR YGLDSD | |
Name | PEDF (Pigment epithelium-derived factor) | |
Length | 399 | |
N-Terminal Modification | Pyrrolidone carboxylic acid | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | Glycosylation at 266th residue, phosphoserine at 5, 95 and 108th residue | |
Origin of Peptide | Neurotrophic protein | |
Nature of Peptide/Cargo | It induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. | |
Mechanism | Neurotrophic protein | |
Cargo Sequence/Structure | None | |
Name of cargo | Not applicable | |
Assay | VEGF and 8-OHdG Immunostaining, Measurement of corneal neo-vascularization via avidin-biotin-alkaline phosphatase kit and statistical analysis | |
Enhancer | None | |
Properties of enhancer | Not applicable | |
Concentration | 1 eye drop of 1 µM thrice a day | |
Incubation time | 0 Day | |
Tissue permeability (value with units) | Neo-vascularized area= 2% due to PEDF (PBS=3%) | |
Tissue Sample | Seven week-old male Spraque–Dawley rat's right eye was used as test and left eye considered as control (PBS) | |
Ex vivo/In vivo/In vitro | in vivo | |
STRUCTURE |
| |
SMILES | N.A. |